CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
复制标题
关于流感的血清ePIDEMIologic研究报告的共识陈述（Roses-I陈述）：频闪陈述的扩展。
DOI：
10.1111/irv.12411
复制
发表时间：
2017-01
影响因子：
4.4
通讯作者：
CONSISE Steering Committee
中科院分区：
文献类型：
--
作者：
Horby PW;Laurie KL;Cowling BJ;Engelhardt OG;Sturm-Ramirez K;Sanchez JL;Katz JM;Uyeki TM;Wood J;Van Kerkhove MD;CONSISE Steering Committee
基于人群的血清学研究是了解流感和其他呼吸道病毒流行病学的重要工具，包括对2009年流感大流行和中东呼吸综合征冠状病毒的传播性和严重程度的早期评估。然而，由于方法的多样性以及缺乏标准化的方法和报告，对血清学研究结果的解释受到了阻碍。CONSISE ROSES ‐I声明的目的是提高流感血清流行病学研究报告的质量和透明度，并促进对已发表结果的有效性和普遍性的评估。ROSES-I声明是CONSISE流行病学和实验室工作组的专家共识。这些建议以报告准则的常见格式提出。由于血清流行病学研究是一种特殊类型的观察性流行病学研究，因此ROSES-I声明建立在STROBE指南的基础上。因此，ROSES-I声明应被视为STROBE指南的延伸。ROSES-I声明列出了42个项目，可用作已发表的血清流行病学研究结果中应包含的信息清单，也可作为研究设计和实施期间需要考虑的项目指南。我们希望ROSES-I声明将有助于提高血清流行病学研究的报告质量。
Population‐based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting. The objective of the CONSISE ROSES ‐I statement was to improve the quality and transparency of reporting of influenza seroepidemiologic studies and facilitate the assessment of the validity and generalizability of published results. The ROSES‐I statement was developed as an expert consensus of the CONSISE epidemiology and laboratory working groups. The recommendations are presented in the familiar format of a reporting guideline. Because seroepidemiologic studies are a specific type of observational epidemiology study, the ROSES‐I statement is built upon the STROBE guidelines. As such, the ROSES‐I statement should be seen as an extension of the STROBE guidelines. The ROSES ‐I statement presents 42 items that can be used as a checklist of the information that should be included in the results of published seroepidemiologic studies, and which can also serve as a guide to the items that need to be considered during study design and implementation. We hope that the ROSES‐I statement will contribute to improving the quality of reporting of seroepidemiologic studies.
登录
查看更多内容
影响因子：
5.4
作者：
Khurana, Surender;Sasono, Pretty;Golding, Hana
通讯作者：
Golding, Hana
影响因子：
3.7
作者：
Nishiura, Hiroshi;Chowell, Gerardo;Castillo-Chavez, Carlos
通讯作者：
Castillo-Chavez, Carlos
影响因子：
11.8
作者：
Stephenson I;Heath A;Major D;Newman RW;Hoschler K;Junzi W;Katz JM;Weir JP;Zambon MC;Wood JM
通讯作者：
Wood JM
影响因子：
2.2
作者：
Mavrouli, Maria D.;Routsias, John G.;Tsakris, Athanassios
通讯作者：
Tsakris, Athanassios
影响因子：
15.8
作者：
Schulz KF;Altman DG;Moher D;CONSORT Group
通讯作者：
CONSORT Group